CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,605,000 | +10.6% | 105,124 | +11.9% | 0.03% | +6.7% |
| Q1 2022 | $2,356,000 | -67.2% | 93,969 | -52.3% | 0.03% | -59.5% |
| Q4 2021 | $7,180,000 | +1405.2% | 197,195 | +453.7% | 0.07% | +1380.0% |
| Q2 2021 | $477,000 | -79.3% | 35,616 | -11.0% | 0.01% | -91.7% |
| Q2 2020 | $2,303,000 | +1499.3% | 40,031 | +286.4% | 0.06% | +445.5% |
| Q1 2019 | $144,000 | – | 10,361 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |